Sivik Global Healthcare’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Hold |
250,000
| – | – | 5.64% | 1 |
|
|
2025
Q1 | $20.3M | Buy |
250,000
+50,000
| +25% | +$4.06M | 10.96% | 1 |
|
|
2024
Q4 | $18M | Sell |
200,000
-100,000
| -33% | -$9.01M | 9.48% | 1 |
|
|
2024
Q3 | $29.6M | Buy |
+300,000
| New | +$29.6M | 12.55% | 1 |
|
|
2024
Q2 | – | Sell |
-300,000
| Closed | -$28.5M | – | 50 |
|
|
2024
Q1 | $28.5M | Buy |
300,000
+164,412
| +121% | +$15.6M | 6.67% | 1 |
|
|
2023
Q4 | $12.1M | Buy |
135,588
+35,588
| +36% | +$3.18M | 5.06% | 1 |
|
|
2023
Q3 | $7.3M | Sell |
100,000
-150,000
| -60% | -$11M | 3.69% | 11 |
|
|
2023
Q2 | $20.8M | Buy |
250,000
+50,000
| +25% | +$4.16M | 4.87% | 1 |
|
|
2023
Q1 | $15.2M | Buy |
200,000
+25,000
| +14% | +$1.91M | 6.55% | 1 |
|
|
2022
Q4 | $14.5M | Buy |
175,000
+163,716
| +1,451% | +$13.6M | 6.83% | 1 |
|
|
2022
Q3 | $895K | Sell |
11,284
-38,716
| -77% | -$3.07M | 0.5% | 40 |
|
|
2022
Q2 | $3.71M | Sell |
50,000
-100,000
| -67% | -$7.43M | 2.11% | 25 |
|
|
2022
Q1 | $13.5M | Buy |
150,000
+50,000
| +50% | +$4.49M | 5.57% | 1 |
|
|
2021
Q4 | $11.2M | Buy |
+100,000
| New | +$11.2M | 4.8% | 1 |
|
|
2021
Q3 | – | Sell |
-100,000
| Closed | -$13.5M | – | 56 |
|
|
2021
Q2 | $13.5M | Buy |
+100,000
| New | +$13.5M | 2.64% | 1 |
|
|
2019
Q1 | – | Sell |
-75,000
| Closed | -$5.38M | – | 65 |
|
|
2018
Q4 | $5.38M | Buy |
+75,000
| New | +$5.38M | 2.9% | 14 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 66 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 64 |
|